Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Morphic Therapeutics
Morphic Therapeutics
Morphic looks to justify “oral Entyvio” excitement
EP Vantage
Wed, 03/15/23 - 10:04 am
Morphic Therapeutics
MORF-057
ulcerative colitis
AbbVie options integrin-based compounds from Morphic, paving way for potential fibrosis treatments
Endpoints
Tue, 08/25/20 - 10:31 am
Morphic Therapeutics
AbbVie
idiopathic pulmonary fibrosis
Back to business for biotech flotations
EP Vantage
Wed, 07/3/19 - 09:48 am
IPOs
BridgeBio
Turning Point Therapeutics
Stoke Therapeutics
Prevail Therapeutics
Atreca
NGM Biopharmaceuticals
Akero Therapeutics
Milestone Pharmaceuticals
Morphic Therapeutics
Karuna
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/23/19 - 02:04 pm
Merck
Keytruda
Melinta Therapeutics
Amag Pharmaceuticals
Palatin
Acer Therapeutics
Sanofi
Regeneron
Alexion
Pfizer
Roche
Navidea Biopharmaceuticals
Ascendis Pharma
Scholar Rock
Adaptive Biotechnologies
BridgeBio
IPOs
G Medical Innovations
Karuna
Morphic Therapeutics
AbbVie Commits $100M to Morphic in Fibrosis Drug R&D Alliance
Xconomy
Thu, 10/18/18 - 11:24 am
AbbVie
Morphic Therapeutics
R&D
fibrosis